000 00914 a2200277 4500
005 20250517202806.0
264 0 _c20190222
008 201902s 0 0 eng d
022 _a1474-5488
024 7 _a10.1016/S1470-2045(18)30150-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWarner, Allison Betof
245 0 0 _aThe brim of uncertainty in adjuvant treatment of melanoma.
_h[electronic resource]
260 _bThe Lancet. Oncology
_c04 2018
300 _a436-437 p.
_bdigital
500 _aPublication Type: Journal Article; Comment
650 0 4 _aDouble-Blind Method
650 0 4 _aHumans
650 0 4 _aMelanoma
650 0 4 _aMutation
650 0 4 _aUncertainty
650 0 4 _aVemurafenib
700 1 _aPostow, Michael A
773 0 _tThe Lancet. Oncology
_gvol. 19
_gno. 4
_gp. 436-437
856 4 0 _uhttps://doi.org/10.1016/S1470-2045(18)30150-5
_zAvailable from publisher's website
999 _c28119387
_d28119387